66 related articles for article (PubMed ID: 9860409)
1. The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage.
Wu CK; Wang JH; Lee CH; Wu KL; Tai WC; Lu SN; Hu TH; Chuah SK
PLoS One; 2013; 8(4):e61666. PubMed ID: 23630607
[TBL] [Abstract][Full Text] [Related]
2. The Risk of
Girleanu I; Trifan A; Huiban L; Muzica C; Nemteanu R; Teodorescu A; Singeap AM; Cojocariu C; Chiriac S; Petrea O; Zenovia S; Nastasa R; Cuciureanu T; Stanciu C
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577887
[No Abstract] [Full Text] [Related]
3. Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan.
Ueno M; Fujiwara T; Tokumasu H; Mano T; Kayahara T; Takabatake H; Morimoto Y; Matsueda K; Fukuoka T; Mizuno M
J Gastroenterol; 2023 Aug; 58(8):766-777. PubMed ID: 37171554
[TBL] [Abstract][Full Text] [Related]
4. Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.
Song S; Yang Y; Geng C; Tang Z; Wang C; Li X
BMC Infect Dis; 2023 Aug; 23(1):557. PubMed ID: 37641014
[TBL] [Abstract][Full Text] [Related]
5. Reply to "Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data".
Ueno M; Fujiwara T; Tokumasu H; Mizuno M
J Gastroenterol; 2024 Feb; 59(2):162-163. PubMed ID: 38091120
[No Abstract] [Full Text] [Related]
6. Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data.
Ichita C; Goto T; Shimizu S
J Gastroenterol; 2024 Feb; 59(2):160-161. PubMed ID: 38112796
[No Abstract] [Full Text] [Related]
7. Novel prevention strategies for bacterial infections in cirrhosis.
Yan K; Garcia-Tsao G
Expert Opin Pharmacother; 2016; 17(5):689-701. PubMed ID: 26799197
[TBL] [Abstract][Full Text] [Related]
8. [Urinary infections without complications: comparison of a treatment with norfloxacin for 7 days versus norfloxacin for 3 days].
García Bernal G; Favà Aixendri E; Rubio Carque V; Luna Jarque J
Aten Primaria; 2002 Jan; 29(1):62-3. PubMed ID: 11820968
[No Abstract] [Full Text] [Related]
9. A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis.
Fricker Z; Jiang G; Patel H; McLaughlin A; Izunza Barba S; Niezen S; Curry M
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180983
[TBL] [Abstract][Full Text] [Related]
10. Serum D-dimer and risk factors for nosocomial infections in cirrhotic patients presenting with upper gastrointestinal bleeding.
Liu M; Ye R; Ye B; Qiu L; Wu X
Minerva Gastroenterol (Torino); 2024 Mar; 70(1):121-123. PubMed ID: 37534862
[No Abstract] [Full Text] [Related]
11. One in four patients with gastrointestinal bleeding develops shock or hemodynamic instability: A systematic review and meta-analysis.
Obeidat M; Teutsch B; Rancz A; Tari E; Márta K; Veres DS; Hosszúfalusi N; Mihály E; Hegyi P; Erőss B
World J Gastroenterol; 2023 Jul; 29(28):4466-4480. PubMed ID: 37576706
[TBL] [Abstract][Full Text] [Related]
12. Update on the management of cirrhosis - focus on cost-effective preventative strategies.
Neff GW; Kemmer N; Duncan C; Alsina A
Clinicoecon Outcomes Res; 2013; 5():143-52. PubMed ID: 23626470
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.
Chavez-Tapia NC; Barrientos-Gutierrez T; Tellez-Avila FI; Soares-Weiser K; Uribe M
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD002907. PubMed ID: 20824832
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study.
Jun CH; Park CH; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS; Kim SJ; Kim YD
J Korean Med Sci; 2006 Oct; 21(5):883-90. PubMed ID: 17043424
[TBL] [Abstract][Full Text] [Related]
15. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.
Wong F; Bernardi M; Balk R; Christman B; Moreau R; Garcia-Tsao G; Patch D; Soriano G; Hoefs J; Navasa M;
Gut; 2005 May; 54(5):718-25. PubMed ID: 15831923
[TBL] [Abstract][Full Text] [Related]
16. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
17. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
18. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
